Sign in Subscribe

U.S. to Permit Temporary Compounding of BPC-157 and Five Other Peptides

Hims & Hers shares rose after HHS said it will temporarily allow compounding pharmacies to produce six popular peptides, including BPC-157, while regulators review formal approval.

U.S. to Permit Temporary Compounding of BPC-157 and Five Other Peptides
"Hims & Hers Acquires US-based Peptide Facility." Credit: Business Wire/Hims & Hers
Already have an account? Sign in.